Gabelli Funds’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Gabelli Funds’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,600	Closed	-$147K	–	1241
2022 Q4	$147K	Hold	14,600	–	–	﹤0.01%	1083
2022 Q3	$145K	Hold	14,600	–	–	﹤0.01%	1182
2022 Q2	$143K	Hold	14,600	–	–	﹤0.01%	1216
2022 Q1	$143K	Hold	14,600	–	–	﹤0.01%	1270
2021 Q4	$141K	Hold	14,600	–	–	﹤0.01%	1287
2021 Q3	$142K	Hold	14,600	–	–	﹤0.01%	1262
2021 Q2	$141K	Buy	+14,600	New	+$143K	﹤0.01%	1257

Gabelli Funds's MSAC Position: Q1 2023 in Review

Gabelli Funds sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 14,600 shares — an estimated $147K sold.

Gabelli Funds first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $147K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Gabelli Funds reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Gabelli Funds sold 14,600 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $147K.
Gabelli Funds first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Gabelli Funds's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $147K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Gabelli Funds's 13F filing for Q1 2023, filed 12 May 2023.